Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

20.09.17	PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra (RTTNews)
18.09.17	Medizone International announces the appointment of David A. Dodd as new Chief Executive Officer (PR Newswire)
14.09.17	Pfizer, Astellas Report Positive Results From XTANDI Phase 3 Trial - Quick Facts (RTTNews)
14.09.17	Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer (PR Newswire)
13.09.17	Should you buy The Gap, McDonald's, Micron, NVIDIA or Pfizer Inc. (PR Newswire)
09.09.17	TINTRI (TNTR) ALERT: Johnson Fistel, LLP Announces Investigation of Tintri, Inc.; Encourages Investors to Contact the Firm for Information (PR Newswire)
08.09.17	FDA Warns Of Manufacturing Violations To EpiPen Plant (RTTNews)
07.09.17	New Drugs Approved In August (RTTNews)
07.09.17	Genentech Recalls Three Lots Of Activase (alteplase) 100mg Vials (RTTNews)
31.08.17	Hospira Recalls 1 Lot Of Vancomycin Hydrochloride For Injection, USP,750 Mg/vial (RTTNews)
30.08.17	APRI Makes 2nd Try, PRQR To Reveal Data On Sep.25, PFE Awaits FDA Decision (RTTNews)
29.08.17	Biotech Stocks Facing FDA Decision In September (RTTNews)
28.08.17	Bristol-Myers, Pfizer Report Investigational Eliquis Data - Quick Facts (RTTNews)
28.08.17	Bristol-Myers: Eliquis Shows Lower Risk Of Stroke In NVAF Patient Subgroups (RTTNews)
25.08.17	Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 Investigational Gene Therapy For Hemophilia A (PR Newswire)
22.08.17	Clinical and Regulatory Progress Boosting Biotech Sector (PR Newswire)
22.08.17	Clinical and Regulatory Progress Boosting Biotech Sector (PR Newswire)
22.08.17	Global Smart Wearable Gloves Market to Grow at a CAGR of 15.2% by 2021: Key Vendors are Blue Infusion Technology, Neofect & ProGlove (PR Newswire)
18.08.17	FDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal (RTTNews)
18.08.17	Pfizer Gets FDA Approval For Rare Blood Cancer Drug Besponsa (RTTNews)
17.08.17	Technical Snapshots for These Drug Makers Stocks -- Pfizer, Eli Lilly, Merck, and Sanofi (PR Newswire)
11.08.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE (PR Newswire)
11.08.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE (PR Newswire)
11.08.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE (PR Newswire)
04.08.17	DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar (RTTNews)
03.08.17	Reflektive Achieves SOC 2 Compliance with Stringent Security Standards (PR Newswire)
01.08.17	Pfizer Q2 Profit Tops Estimates, Revenues Miss; Lifts FY17 Earnings View (RTTNews)
01.08.17	Pfizer Inc. Reports 3% Rise In Q2 Earnings (RTTNews)
31.07.17	ICU Medical Recalls One Lot Of 0.9% Sodium Chloride Injection (RTTNews)
31.07.17	Biotech Stocks Facing FDA Decision In August (RTTNews)
25.07.17	ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings (PR Newswire)
25.07.17	ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings (PR Newswire)
25.07.17	ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings (PR Newswire)
25.07.17	ViiV Healthcare Reports Positive Interim Results From DAWNING - Quick Facts (RTTNews)
25.07.17	GSK : ViiV Healthcare Announces Results From NEAT 022 Study (RTTNews)
24.07.17	Pfizer Says REFLECTIONS B7391003 Study Met Primary Objective - Quick Facts (RTTNews)
24.07.17	GlaxoSmithKline: ViiV Healthcare Presents 96-week Data From LATTE-2 Study (RTTNews)
21.07.17	EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma (PR Newswire)
20.07.17	Pfizer Obtains Exclusive Commercialization Rights In Europe To CRESEMBA (RTTNews)
14.07.17	FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33% (RTTNews)
13.07.17	Pfizer: FDA Accepts SNDA For Xeljanz For Treatment Of Ulcerative Colitis (RTTNews)
12.07.17	ORMP To Meet With FDA, Second Time's No Charm For OCUL, Panel Backs PFE (RTTNews)
30.06.17	Pfizer Reports European Commission's Approval Of BESPONSA - Quick Facts (RTTNews)
29.06.17	Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar™ Advanced Intrathecal Precision Delivery Platform Technology for use in Gene... (PR Newswire)
29.06.17	Biotech Stocks Facing FDA Decision In July (RTTNews)
26.06.17	Breakfast Technical Briefing on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
21.06.17	S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 (PR Newswire)
16.06.17	Pfizer Reports Overall Efficacy In Xeljanz Oral Safety Study (RTTNews)
15.06.17	ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar (RTTNews)
14.06.17	Patented Biotechnology Formulations Resulting in New Generation of Animal Healthcare Medications and Treatments (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

07:18		Roche-Aktie: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt
18.12.24		Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten
18.12.24		Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX
18.12.24		Börse Zürich in Rot: SPI schliesst in der Verlustzone
18.12.24		Pluszeichen in Europa: STOXX 50 letztendlich fester
18.12.24		Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester
18.12.24		Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus
18.12.24		Aufschläge in Frankfurt: SDAX steigt zum Handelsende

07:18

Roche-Aktie: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt

18.12.24

Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten

18.12.24

Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX

18.12.24

Börse Zürich in Rot: SPI schliesst in der Verlustzone

18.12.24

Pluszeichen in Europa: STOXX 50 letztendlich fester

18.12.24

Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester